After six months of treatment, medicines called 'biologics' seem to work best to clear raised patches of psoriasis on the skin. Longer studies are needed to assess the benefits and potential unwanted ...

What are the benefits and risks of natalizumab (NTZ) in people with multiple sclerosis (MS)?

Improvement in IIM activity, as measured by the International Myositis Assessment and Clinical Studies Group (IMACS) definitions of improvement (DOI), may be more likely with abatacept treatment ...

There is limited evidence to support the use of tumor necrosis factor-alpha antagonists (anti-TNF) therapy for induction of remission in children with Crohn's disease. • More well-designed studies are ...

Due to a lack of robust evidence, we could not determine the benefits and unwanted effects of hospital networks (organised trauma systems) or individual hospitals (designated trauma centres) that are ...

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas ...

Cochrane est un réseau mondial, indépendant et à but non lucratif de chercheurs et professionnels de santé, de patientèle et de soignants qui travaillent ensemble pour produire et promouvoir des ...

Мы спасаем и улучшаем жизни людей с помощью лучших доказательств о здоровье и здравоохранении Кокрейн - это глобальное, независимое, некоммерческое (не для ...

Cochrane es una red global, independiente y sin ánimo de lucro formada por personas investigadoras y profesionales de la salud, pacientes y personas cuidadoras que trabajan juntas para producir y ...

Cochrane ist ein globales, unabhängiges und gemeinnütziges Netzwerk. Darin arbeiten Forschende und Fachleuten aus dem Gesundheitswesen, Patient*innen und Pflegenden zusammen, um zuverlässige, ...

Des statistiques qui sauvent des vies Nous examinons les données probantes qui sous-tendent les questions affectant la vie des gens, leur donnant les moyens de prendre de meilleures décisions.